Latest News and Press Releases

Galapagos is van plan een strategische samenwerking aan te gaan met Gilead, na de overname van Ouro Medicines door Gilead De nieuwe partnerstructuur zou aanzienlijk verbeterde financiële voorwaarden...

Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms...

Daix (France), New York (États-Unis), le 23 mars 2026 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une...

Daix (France), New York (United States), March 23, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the...

London, United Kingdom, March 23, 2026 (GLOBE NEWSWIRE) --  As part of its latest platform update, LotmentCapital has officially announced a significant enhancement of its technological...

Mumbai, Maharashtra, March 23, 2026 (GLOBE NEWSWIRE) -- With multi-city Vietnam trips often involving flights, ferries and overnight transfers, HDFC ERGO highlights why online holiday insurance...

Déclaration des transactions sur actions propresréalisées entre le 16 et le 20 mars 2026 Paris – 23 mars 2026 Programme de rachat d’actions adopté par l’Assemblée Générale du 27 mai 2025. Détails...

Disclosure of trading in own shares from March 16 to 20, 2026 Paris – March 23, 2026 Share repurchase program approved by the Shareholders’ Meeting of May 27, 2025. Transaction Details: Publicis...

Consensus de Voltalia au 23 mars 2026 Voltalia (Euronext Paris, code ISIN : FR0011995588), acteur international des énergies renouvelables, publie le consensus des analystes actions, au 23 mars 2026....

Voltalia’s consensus as of March 23, 2026 Voltalia (Euronext Paris, code ISIN: FR0011995588), an international player in renewable energies, publishes the equity analysts’ consensus, as of March 23,...